The Organizing Committee of the WCTC is pleased to announce that the 2022 virtual program is being supported by Eisai, Eli Lilly & Company and Medtronic. We will be actively seeking industry partners who will play a vital role in the delivery of future events including:
2023 – London, UK
2025 – Boston, MA
Providing a commitment to Continuing Medical Education, through unrestricted grants and donations, ensures that meeting participants can gain the maximum possible benefit from the educational opportunities provided by WCTC. The faculty and delegates provide an exceptional opportunity for corporate supporters to interact with leaders in the field of thyroid nodules and thyroid cancer, including Endocrinologists, Surgeons, Oncologists, Radiologists and Nuclear Medicine Specialists.
WCTC has a global reputation for producing the most cutting-edge, comprehensive education – join us!